SENORES PHARMACEUTICALS L

SENORES

Small Cap | Pharmaceuticals
₹903.5
-13.2 (-1.43%)

Stock price as on 29 Apr 2026 at 15:30 PM

Senores pharmaceuticals l share price update

As of the latest trading session, Senores Pharmaceuticals L share price is currently at ₹903.5, which is down by ₹-13.2 from its previous closing. Tod...

Senores Pharmaceuticals L stock performance

Today’s low

₹900.6

Today’s high

₹920

₹903.5

52 week low

₹475

52 week high

₹947.7

₹903.5
Open
₹915.10
Previous close
₹916.70
Share volume
68,103
Total traded value (Lakh)
₹618.98
Upper circuit
₹1,100.00
Lower circuit
₹733.40

Senores Pharmaceuticals L fundamentals

Market cap (Cr)
₹4,189.70
P/E ratio (TTM)
306.79
Book value per share
₹155.05
Beta
0.92
Return on equity
0.84%
Earnings per share (TTM)
₹2.99
Dividend yield
0%
Net profit/quarter (Cr)
₹2.65

Senores Pharmaceuticals L technical summary

₹909.75
-0.75 ▼
1
Bearish
15
Bullish
5 Day909.8
10 Day890.7
12 Day882.9
20 Day857.1
26 Day844.1
50 Day818.7
100 Day795.8
200 Day743.8
5 Day906.2
10 Day897.7
12 Day886.3
20 Day844
26 Day820.9
50 Day797.5
100 Day802.7
200 Day756.7

897.37

PIVOT

First support
₹879.78
First resistance
₹908.73
Second support
₹868.42
Second resistance
₹926.32
Third support
₹850.83
Third resistance
₹937.68
RSI
65.49
ADX
31.27
MACD
35.17
Williams % R
-29.56
Commodity Channel Index (CCI)
92.57
Date
24 Apr 2026
Same day
2,62,164
Week
1,94,114
Month
1,53,293
1 year
0.88
3 years
1.21
Over 1 month
21.67%
Over 1 year
67.35%
Over 3 months
12.64%
Over 3 years
0%
Over 6 months
15.96%
Over 6 years
0%

Investment Returns

Over 1 Month21.67%
Over 3 Months12.64%
Over 6 Months15.96%
Over 1 Year67.35%

Senores Pharmaceuticals L Shareholding pattern


Public
40.93%
Promoter holdings
45.81%
FII
3.63%
DII
9.61%
Promoter shares
1.9%
Promoter sharesShareCategory

Swapnil Jatin Shah

35,53,531 (7.72%)

Shareholding of Promoter and Promoter Group

Ashokbhai Vijaysinh Barot

34,44,869 (7.48%)

Shareholding of Promoter and Promoter Group

Remus Pharmaceuticals Limited

32,61,744 (7.08%)

Shareholding of Promoter and Promoter Group

Renosen Pharmaceuticals Private Limited

27,18,719 (5.9%)

Shareholding of Promoter and Promoter Group

Anar Swapnil Shah

22,94,500 (4.98%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Swapnil Jatin Shah35,53,531 (7.72%)Shareholding of Promoter and Promoter Group
Ashokbhai Vijaysinh Barot34,44,869 (7.48%)Shareholding of Promoter and Promoter Group
Remus Pharmaceuticals Limited32,61,744 (7.08%)Shareholding of Promoter and Promoter Group
Renosen Pharmaceuticals Private Limited27,18,719 (5.9%)Shareholding of Promoter and Promoter Group
Anar Swapnil Shah22,94,500 (4.98%)Shareholding of Promoter and Promoter Group
Aviraj Overseas Llc18,95,190 (4.12%)Shareholding of Promoter and Promoter Group
Aditya Birla Sun Life Insurance Company Limited13,63,254 (2.96%)Public Shareholding
Hsbc Mutual Fund - Hsbc Value Fund10,55,025 (2.29%)Public Shareholding
Sangeeta Mukur Barot10,42,955 (2.26%)Shareholding of Promoter and Promoter Group
Manoj Prakash Sanghvi8,54,484 (1.86%)Public Shareholding
Ratnamani Marketing Private Limited8,38,000 (1.82%)Public Shareholding
Astorne Capital Vcc - Arven7,05,346 (1.53%)Public Shareholding
Aviraj Group Llc6,84,750 (1.49%)Shareholding of Promoter and Promoter Group
Mahindra Manulife Large & Mid Cap Fund6,47,000 (1.4%)Public Shareholding
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund6,32,670 (1.37%)Public Shareholding
Jayanti Mishrimal Sanghvi .5,67,823 (1.23%)Public Shareholding
Jigar Prakash Sanghvi5,49,523 (1.19%)Public Shareholding
Espee Therapeutics Llp4,95,000 (1.07%)Shareholding of Promoter and Promoter Group
Jitendra Babulal Sanghvi4,88,516 (1.06%)Shareholding of Promoter and Promoter Group
Prakash Mishrimal Sanghvi4,76,190 (1.03%)Public Shareholding
Mukur Yogeshkumar Barot4,56,825 (0.99%)Shareholding of Promoter and Promoter Group
Shantaben Babulal Sanghvi3,28,569 (0.71%)Shareholding of Promoter and Promoter Group
Dhananjay Ashokkumar Barot3,12,689 (0.68%)Shareholding of Promoter and Promoter Group
Hemant Ishwarlal Modi62,000 (0.13%)Shareholding of Promoter and Promoter Group
Jatin Siddharthbhai Shah30,000 (0.07%)Shareholding of Promoter and Promoter Group
Pinky Jatin Shah30,500 (0.07%)Shareholding of Promoter and Promoter Group

About SENORES PHARMACEUTICALS L

Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre. Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in

Parent Organisation

Indian Private

NSE Symbol

SENORES

Founded

2017

SENORES PHARMACEUTICALS L CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

RASRESOR

RAS RESORTS & APART HOTELS LTD

59.04
+9.84 (+20%)
MGIL

MARUTI GLOBAL INDUSTRIES LIMIT

43.87
+7.31 (+19.99%)
ABANSENT

ABANS ENTERPRISES LTD

40.94
+6.82 (+19.99%)
RAL

RESOURCEFUL AUTOMOBILE LIMITED

43.35
+7.22 (+19.98%)
View all

Top gainers

ITC

ITC LTD

316.25
+11.80 (+3.88%)
TECHM

TECH MAHINDRA LIMITED

1459.8
+51.70 (+3.67%)
MARUTI

MARUTI SUZUKI INDIA LTD.

13257
+365.00 (+2.83%)
COALINDIA

COAL INDIA LTD

479.9
+12.90 (+2.76%)
View all

Top losers

INDIGO

INTERGLOBE AVIATION LTD

4345.2
-97.20 (-2.19%)
DRREDDY

DR. REDDY S LABORATORIES

1329.8
-24.80 (-1.83%)
NTPC

NTPC LTD

401.3
-5.55 (-1.36%)
ICICIBANK

ICICI BANK LTD.

1281
-11.00 (-0.85%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)